Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 08/27/2024 10:52:21 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 585
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70987
Found this post on another site. Am currently
(7)
petemantx
12/30/2021 4:49:55 PM
70982
Hope everyone had a Merry Christmas and is
(7)
scgmck1
12/29/2021 10:25:24 PM
70980
Initially I was very disturbed with the PR
(8)
petemantx
12/27/2021 8:38:39 PM
70979
As frustrations mount over the need for, what
(2)
Commando911
12/27/2021 12:52:02 AM
70978
So if you have migraines or certain heart
(3)
Drano
12/27/2021 12:07:13 AM
70977
Ritonavir, part of part of Pfizer's covid pill
(5)
farrell
12/26/2021 11:43:01 PM
70976
Great post farrell. We have all read about safety
(6)
Mo
12/26/2021 11:49:20 AM
70975
At this point none of the other antiviral drugs
(11)
farrell
12/26/2021 10:59:11 AM
70972
Thanks and same to you and the board as well.
(3)
Kelt
12/25/2021 3:14:01 PM
70968
Second the motion. Merry Christmas and let's hope
(5)
Drano
12/25/2021 11:02:42 AM
70967
Merry Christmas to you and all who
(5)
someconcerns
12/25/2021 6:31:36 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
< Previous
Next >
Recent Articles
Kalmar and BlueScope Unite for Major Forklift Supply Agreement
Datalec Precision Installations Strengthens APAC Data Center Presence
Pepper Advantage Partners with Arctic Wolf for Cyber Security
LG Innotek Pioneers AI in Raw Material Quality Assurance
Fleet Management Welcomes New CEO to Drive Future Growth
Norlantic Capital and JTC Group Launch Dynamic Investment Fund
DFI Showcases Its Cutting-Edge Edge AI Solutions at Exhibition
Exploring the Expansive Benefits of Vitamin D on Health
Discover Autumn Savings: Up to 46% Off Jackery's Energy Solutions
Ford Motor Company Faces Class Action Lawsuit for Securities Issues
Vitamin D's Widespread Impact: Insights from Leading Experts
Exciting Discounts on Jackery Energy Solutions for Fall Season
Valeo's Current Voting Rights and Corporate Overview
Challenges Faced by German Retail Sector Amid Economic Uncertainty
Positive Employment Report Soothes Recession Fears in US
Market Insights: Japan's Nikkei 225 Rises with Strong Performance
Shell's Refining Margins Plummet in Q3 Amid Market Volatility
Insights from the European Blockchain Convention on Future Trends
Mastering Your Approach: 10 Tips to Secure Prop Firm Approval
Market Watch: Igniting Conversations on CPI and Wage Trends
Market Valuations Indicate Potential Challenges Ahead
Analyzing the Market: Will Retail Stocks Drive Upcoming Trends?
S&P 500 Shows Resilience as Bulls Hold Support Levels Steady
Vegan Dips Market Expected to Surpass $413 Million by 2032
EPSO-G Elects New Members to Its Audit Committee
Ubisoft's Strategic Focus and Future Directions Revealed
Latest Insights into Atos's Negotiations with French Authorities
ISS A/S Executes Strategic Share Buyback Program for Growth
Innovative Manganese-Based MRI Contrast Agent Shows Promise
LTL Multifamily II B.V. Engages Global Investors for New Opportunities
Upcoming Earnings: Key Stocks to Monitor This Week
Navigating Market Shifts Amid Political Changes and Rate Cuts
Thyssenkrupp Evaluates Future of Green Steel Initiatives
Tokyo Metro's Ambitious IPO Plans Set to Transform Capital Market
MaxLinear's Innovative AI Framework Enhances Wi-Fi for Users
Growth Trends in Tesla's Supercharger Network and Future Plans
Shell's Q3 2024 Financial Outlook and Key Insights
Exploring Len Sassaman's Possible Connection to Bitcoin's Creator
JPMorgan's David Kelly Advises Caution to Investors Amid Risks
Innovative Drilling Initiative at Klippen Project Unveiled
Mérieux NutriSciences Expands Global Reach with Strategic Acquisition
Kojamo's Leadership Transition: Insights on the CEO Departure
Mérieux NutriSciences Expands Food Testing Reach with Major Acquisition
Trump Proposes Striking Tariff on Mexican Vehicle Imports
Florida Braces for Hurricane Milton Amid Recovery from Helene
Taiwanese Market Overview: Stocks Experience Notable Fluctuations
BP's Strategic Shift: Focus on Oil Output to Regain Investor Trust
Carl Joachim's Legacy in Digital Packaging and Innovation
IMU Biosciences Partners in Innovative Cancer Research Consortium
Fighting eCommerce Fraud: Trends and Prevention Strategies
Coringa Gold Project's Updated Economic Assessment Revealed
Chinese Chip Sector Gains Momentum With $13 Billion Rally
Shell's Enhanced Q3 2024 Financial Outlook and Performance Insights
OSB Group PLC Updates PDMR Transactions: Correction Notice
PayPoint Discovers Success in Recent Share Buyback Initiative
Vast Resources plc: Enhancing Financial Stability Amid Challenges
Subsea7 Expands Share Buyback Program Amid Market Trends
Transgene Showcases Promising Results for TG4050 Vaccine
21Shares Promotes Unified Regulatory Framework for Crypto ETPs
OSB Group Executes Share Buyback with Significant Volume
Subsea 7 S.A. Enhances Employee Engagement with Share Transfers
Exor N.V. Enhances Shareholder Value Through Buyback Efforts
Innovative Drug Development Solutions at CPHI Milan 2024
ViroCell Biologics Eagerly Anticipates Upcoming Panel Event
Soho Square's Strategic Exit from Assured Data Protection
Medinol's Innovative ChampioNIR Stent Reaches Major Milestone
Exciting Updates for the 2024 Utsunomiya Japan Cup Cycle Race
EPAM Expands Services with Acquisition of First Derivative
EPAM Systems Expands Financial Services Practice with Acquisition
LG Energy Solution Embraces Future with Bold Corporate Vision
Advantech Introduces Innovative IEC 62443 Certification Service
Australia's Stock Market Gains Steam with ASX 200 Rise
How Changing U.S. Jobs Report Affects Market Dynamics
Boussard & Gavaudan Holding Ltd: Key NAV Insights for Investors
Recent Developments in Sampo plc’s Share Buyback Strategy
Rubis Initiates Strategic Share Buyback Initiative Today
Boussard & Gavaudan Holding's Latest NAV and Market Insights
Strategic Leadership Changes Poised to Enhance Vaisala's Growth
Bureau Veritas Sells Food Testing Business, Aligns with LEAP Strategy
Mytheresa's Strategic Acquisition of YNAP Enhances Luxury Portfolio
Bureau Veritas Expands BIM Services by Acquiring IDP Group
Mytheresa's Strategic Acquisition of YNAP for Luxury Leadership
Bureau Veritas Strengthens Portfolio with Strategic Business Sale
Exploring Energy Transition Innovations with Black & Veatch
Bureau Veritas Strengthens BIM Capabilities with IDP Group Deal
D-Link's AQUILA PRO AI Honored as Top AI Product of the Year
Bank of Japan Notes Expanding Price and Wage Increases
Bitcoin Soars Above $63k Driven by Economic Optimism
Exciting New Opportunities with EVAL Listing on XT Exchange
LG Energy Solution's Vision: Pioneering the Circular Energy Market
BerGenBio's Phase 1b Trial Shows Promise for NSCLC Treatment
BerGenBio's Trial Provides Encouraging Safety Data for NSCLC
Market Impacts from Unexpected Job Growth and Interest Rates
Asian Market Upturn Driven by U.S. Jobs Report Insights
BioSenic Investors Receive Transparency Notification from ABO
Galapagos Appoints Oleg Nodelman to Board for Strategic Growth
Amundi Unveils Share Repurchase Initiative to Enhance Value
Breaking Boundaries: Dassault Systèmes Celebrates New Record
Crystal Teams with BitOasis to Elevate Trading Security
Oleg Nodelman Joins Board of Directors at Galapagos NV